Just your not so average Thursday afternoon for a dude with Duchenne and his momma. A conversation that needed to happen, but this momma had been struggling to find the right time to have it. Dreading revealing a secret that I have been keeping from Jake, but also hiding it was just as dreadful. Sometimes the Universe does not give you a choice and presents you with a golden ticket in the form of an opportune moment. Do you take it? Do you crumple it up and toss it into oblivion you like…
ContinueAdded by Danielle Bath on April 30, 2013 at 6:00pm — 6 Comments
Parent Project Muscular Dystrophy and DuchenneConnect are happy to present the 2012 DuchenneConnect Year-End Report! Read about the registry’s accomplishments in 2012 and goals for 2013. We had a busy and exciting year as we…
Added by Ann Martin on April 30, 2013 at 10:55am — No Comments
I have met some amazingly innovative people in my travels. Many who are dedicated to improving the lives of those living with rare diseases. Wendy White is one of those people. Wendy is the founder of Siren Interactive. Siren is a digital relationship marketing agency focused exclusively on addressing the…
Added by Pat Furlong on April 29, 2013 at 10:00am — No Comments
PPMD President Pat Furlong and Vice President of Research Sharon Hesterlee are attending MDA’s Scientific Conference this week in Washington, D.C. Most of what was presented are results that were previously announced. However, there were some interesting presentations, as well as, results worth repeating, that we wanted to share. Sharon and Pat will continue to blog from the conference:
From Pat Furlong
Interview with Thomas Voit
While the content…
ContinueAdded by PPMD on April 24, 2013 at 10:00am — 6 Comments
Below is the latest update PPMD has received from Dr. Rohit Batta, Global Medical Affairs and Patient Relations Leader in GSK's Rare Disease Unit :
ContinueThe purpose of this communication is provide an update to you, as you have requested, on GSK’s plans for providing the option of continued access to drisapersen for boys completing the US Ph IIb 48 week study (DMD114876)…
Added by PPMD on April 24, 2013 at 9:30am — No Comments
PPMD is proud to share an advance copy of Putting Patients First, a white paper outlining…
Added by Pat Furlong on April 22, 2013 at 12:00pm — No Comments
Guest post by Gail D. McVicker, Grandmother of Jake (10) and Ryan (6) - Pennsylvania
Duchenne: An Intergenerational Issue
Five years ago, I did not know the world of Duchenne muscular dystrophy existed. Before my young grandsons were officially diagnosed in 2008, my daughter told me that some genetic…
ContinueAdded by PPMD on April 17, 2013 at 2:49pm — 2 Comments
As you know, each month we feature someone in the community with Duchenne, that has done something really special to raise awareness and help us in our fight. This month, we are featuring 17-year-old Matt Scheivert, who doesn’t have Duchenne, but has already decided that he wants to continue to work in Duchenne research and advocacy. He plans to attend…
Added by Will Nolan on April 17, 2013 at 2:22pm — No Comments
PPMD received the email update below from Hans Schikan at Prosensa:
Dear all,
Today, at the Cold Spring Harbor conference in the US, Dr John Kraus of GSK gave an excellent presentation on the outcome of the 117 (DEMAND II) clinical trial. The primary endpoint in this exploratory study was met and a statistically and clinically meaningful difference of 35 meters in the six-minute walk test between the continuous dosing regimen of 6mg/kg per week and placebo was…
ContinueAdded by PPMD on April 12, 2013 at 11:39am — No Comments
This spring brings news of progress to the Duchenne community as Sarepta engages in talks with the Food and Drug Association (FDA) to determine if they agency will review an application for accelerated approval for the exon 51 skipping drug eteplirsen and releases its 74 month data…
ContinueAdded by Sharon Hesterlee on April 9, 2013 at 9:00pm — 5 Comments
Below is the latest update PPMD has received from Dr. Rohit Batta, Global Medical Affairs and Patient Relations Leader in GSK's Rare Disease Unit :
ContinueTo keep you updated on the progress of the drisapersen (previously GSK2402968) clinical development program, as you have requested, I am writing to inform you that the results of the GSK Phase IIb study investigating drisapersen as…
Added by PPMD on April 5, 2013 at 10:51am — No Comments
Guest post by Ivy Scherbarth. Ivy is a Colorado/Wyoming FACES Coordinator for PPMD. Follow Ivy at her blog, Living Duchenne.
One interesting thing about silence is listening to…
ContinueAdded by PPMD on April 4, 2013 at 11:30pm — No Comments
Funeral dirge. Hearts break so many times, it is impossible to keep track. A tidal wave of memories, nearly too much to bear. Minds racing, reviewing the journey that was Duchenne and all of the ‘what ifs’ and ‘if only’ that remain. Ryan’s father, mother, sisters – raw and alone, returning to the home once overflowing with Ryan and now empty.
I met Howard Kaplan many years ago in Chicago. He is a tall, broad shouldered man and in the business of protection. His company,…
ContinueAdded by Pat Furlong on April 4, 2013 at 11:24pm — No Comments
A Call to Action for all NH Constituents!
Seacoast, New Hampshire- 8th grader Rebecca Gowing wanted to make a difference in her community. After learning that her sister’s classmate and friend, Lucas Currier, had Duchenne Muscular Dystrophy she took action to help raise funds and spread awareness, creating Art for A Cure…
ContinueAdded by Ryan Fischer on April 2, 2013 at 9:00pm — No Comments
Hello Duchenne community!
Summer is just around the corner and with that comes sunshine, fireflies and PPMD’s Annual Connect Conference.
We are excited to be back in Baltimore, MD at the beautiful Marriott Waterfront this year and really excited about this year’s program.
In 2013…
ContinueAdded by Kimberly Galberaith on April 2, 2013 at 11:30am — No Comments
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service